Overview

Post C-Section Pain Control Using EXPAREL

Status:
Withdrawn
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
Evaluating the safety and efficacy of EXPAREL (Liposomal Bupivacaine ) for pain control in patients undergoing scheduled cesarean section by giving it either as infiltration in Transversus Abdominis Plane after finishing the procedure or through wound infiltration into the fascia prior to closure of skin
Phase:
Phase 4
Details
Lead Sponsor:
University of Minnesota